Position in UPB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,021,144
-$5,116,183 QoQ
Shares Held
2,459,703
0.0% QoQ
Ownership
4.49%
of shares outstanding
% of Portfolio
4.93%
of 13F equity value
Holder Rank
#6
of 148 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UPB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENAVATE SCIENCES GP, LLC holds $345,377,328 across 7 Biotechnology names. UPB ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SION |
Sionna Therapeutics, Inc.
|
2,478,030 | $109,008,539 | |
| 2 | ZBIO |
Zenas BioPharma, Inc.
|
3,919,159 | $99,468,255 | |
| 3 | IMNM |
Immunome Inc.
|
3,613,799 | $76,576,400 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,626,946 | $20,017,328 | |
| 5 | CMPX |
Compass Therapeutics, Inc.
|
7,788,150 | $17,056,048 | |
| 6 | UPB |
Upstream Bio, Inc.
This page
|
2,459,703 | $17,021,144 | |
| 7 | CAMP |
Camp4 Therapeutics Corp
|
1,425,541 | $6,229,614 |
All Filings in UPB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,021,144 | 2,459,703 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,137,327 | 2,459,703 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $66,780,936 | 2,459,703 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $46,267,013 | 2,459,703 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,007,538 | 2,459,703 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,053,382 | 2,459,703 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $40,437,517 | 2,459,703 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||